Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
Bulletin Du Cancer|January 1, 1978
[Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)]J Chauvergne, P Cappelaere, M Carton, et al.Bulletin Du Cancer|January 1, 1979
[Invasive carcinoma of the uterine cervix associated with pregnancy (author's transl)]M Verhaeghe, P Cappelaere, J Rohart, et al.Bulletin Du Cancer|January 1, 1991
[Continuous Holter cardiac monitoring and chemotherapy by combination with platinum and fluoro-uracil]P Cappelaere, A Vincent, M Staumont, et al.Bulletin Du Cancer|January 1, 1983
[Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease]P Cappelaere, J L Lai, A Caty, et al.Bulletin Du Cancer|January 1, 1980
[Chemotherapy in cervical cancer. Assessment of 267 palliative treatments and current trends (author's transl)]J Chauvergne, M Durand, P Cappelaere, et al.Bulletin Du Cancer|January 1, 1981
[Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)]P Cappelaere, J Chauvergne, T Klein, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 23, 1982
[Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both]B Clavel, J P Cappelaere, J Guerin, et al.European Journal of Cancer & Clinical Oncology|November 1, 1982
Prolactin receptors in human breast cancerJ Bonneterre, J P Peyrat, B Vandewalle, et al.Bulletin Du Cancer|January 1, 1990
[Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer]P Fumoleau, P Bastit, D Horner, et al.Pathologie-Biologie|November 1, 1984
[Receptors for steroid hormones apart from breast cancer. Practical value]P Vennin, J P Peyrat, J Bonneterre, et al.Pageof 7